Developing real-world prognostic models for patients with advanced hepatocellular carcinoma: CRAFITY, mALF and beyond

Prognostic impact of C-reactive protein and alpha-fetoprotein in immunotherapy score in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: a multicenter retrospective study

(2022) Takeshi Hatanaka et al.   Hepatology International

Development and validation of a modified albumin–bilirubin grade and α-fetoprotein score (mALF score) for hepatocellular carcinoma patients receiving atezolizumab and bevacizumab

(2022) Takeshi Hatanaka et al.   Hepatology International

Easy albumin–bilirubin score as a new prognostic predictor in hepatocellular carcinoma

(2021) Shu‐Yein Ho et al.   HEPATOLOGY RESEARCH

Long-Term Outcomes of Antiviral Therapy in Patients With Advanced Chronic HBV Infection

(2019) Hye Won Lee et al.   Clinical Gastroenterology and Hepatology

A New Prognostic Model Based on Albumin–Bilirubin Grade for Hepatocellular Carcinoma Beyond the Milan Criteria

(2019) Shu-Yein Ho et al.   DIGESTIVE DISEASES AND SCIENCES

Proposal and validation of a new model to estimate survival for hepatocellular carcinoma patients

(2016) Po-Hong Liu et al.   EUROPEAN JOURNAL OF CANCER

Real-world risk score for hepatocellular carcinoma (RWS-HCC): a clinically practical risk predictor for HCC in chronic hepatitis B

(2016) Zhongxian Poh et al.   GUT

A new prognostic model for hepatocellular carcinoma based on total tumor volume: The Taipei Integrated Scoring system

(2010) Chia-Yang Hsu et al.   JOURNAL OF HEPATOLOGY